Community-Based Participatory Research Programs
Gilead Sciences' CBPR Program funds community-led, drug-agnostic research to improve health outcomes and care quality for diverse and underserved populations.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026: Letter of Interest deadline (projected) | August 2026: Full application deadline (projected)
Funding Amounts: Funding varies by project; typical awards and durations are not specified.
Summary: Supports community-led, drug-agnostic research projects aiming to improve health outcomes and care quality for diverse and underserved populations.
Key Information: Letter of Interest required before full proposal; only community-based organizations are eligible.
Description
Gilead Sciences' Community-Based Participatory Research (CBPR) Programs provide funding to support research initiatives led or co-led by community-based organizations. The aim is to improve health outcomes, services, and quality of care for diverse local populations, particularly those with significant or unmet health needs. Projects must be drug-agnostic and can address a variety of therapeutic areas, including but not limited to HIV, oncology, and liver diseases. The program emphasizes the importance of engaging organizations deeply rooted in their communities to lead innovative research that responds directly to local health challenges.
